TIC10 compound
Showing 1 - 25 of 3,408
Colorectal Adenomatous Polyp, Colorectal Carcinoma, Familial Adenomatous Polyposis Trial in United States (procedure, drug,
Not yet recruiting
- Colorectal Adenomatous Polyp
- +3 more
- Biopsy
- +5 more
-
Ann Arbor, Michigan
- +4 more
Jan 3, 2023
Triple Negative Breast Cancer Trial in Madison (Akt/ERK Inhibitor ONC201, Methionine-Restricted Diet)
Terminated
- Triple Negative Breast Cancer
- Akt/ERK Inhibitor ONC201
- Methionine-Restricted Diet
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Feb 11, 2022
Leber Congenital Amaurosis 10, Inherited Retinal Dystrophies, Eye Diseases, Hereditary Trial in United States (EDIT-101)
Active, not recruiting
- Leber Congenital Amaurosis 10
- +6 more
-
Miami, Florida
- +4 more
Dec 2, 2022
Malignant Ovarian Epithelial Tumor, Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma Trial in
Recruiting
- Malignant Ovarian Epithelial Tumor
- +9 more
- Akt/ERK Inhibitor ONC201
- +2 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
May 10, 2022
CNS Lymphoma, Gastric Mantle Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Houston (Akt/ERK Inhibitor ONC201,
Terminated
- Central Nervous System Lymphoma
- +6 more
- Akt/ERK Inhibitor ONC201
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Mar 30, 2022
Healthy Trial in Ciudad de México (Tirfostina/L-Carnitina)
Enrolling by invitation
- Healthy
- Tirfostina/L-Carnitina
-
Ciudad de México, Azcapotzalco, MexicoPharmet, S.A de C.V.
Aug 2, 2022
Open Angle Glaucoma, Ocular Hypertension Trial in United States (OTX-TIC low dose Travoprost Intracameral Implant, OTX-TIC high
Recruiting
- Open Angle Glaucoma
- Ocular Hypertension
- OTX-TIC low dose Travoprost Intracameral Implant
- +2 more
-
Delray Beach, Florida
- +8 more
Apr 12, 2022
Therapeutic Equivalency Trial in Qingdao (compound lisinopril tablet, compound lisinopril tablet(Lisonorm®))
Completed
- Therapeutic Equivalency
- compound lisinopril tablet
- compound lisinopril tablet(Lisonorm®)
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University
May 9, 2021
Advanced Glioblastoma, Advanced Colorectal Cancer, Advanced Triple-negative Breast Cancer Trial in Boston (ONC201)
Withdrawn
- Advanced Glioblastoma
- +3 more
-
Boston, MassachusettsMassachusetts General Hospital
Apr 28, 2021
Recurrent Glioblastoma, Recurrent Gliosarcoma, Recurrent Supratentorial Glioblastoma Trial in Los Angeles (drug, radiation,
Withdrawn
- Recurrent Glioblastoma
- +3 more
- Akt/ERK Inhibitor ONC201
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
May 10, 2021
H3 K27M, Glioma Trial in Santa Monica (ONC201, ONC201 + Placebo, Placebo)
Recruiting
- H3 K27M
- Glioma
- ONC201
- +2 more
-
Santa Monica, CaliforniaProvidence Saint John's Cancer Institute
Nov 28, 2022
Endometrial Cancer, Metastasis Trial (Atezolizumab, ONC201)
Not yet recruiting
- Endometrial Cancer
- Metastasis
- (no location specified)
Sep 12, 2022
Recurrent Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Cleveland (ONC201)
Completed
- Recurrent Neuroendocrine Tumor
- Metastatic Neuroendocrine Tumor
-
Cleveland, OhioCleveland Clinic Pediatric and Taussig Cancer Institute, Case Co
Dec 1, 2022
Meningioma, Refractory Meningioma, Relapsed Meningioma Trial in Omaha (ONC201)
Not yet recruiting
- Meningioma
- +2 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Aug 21, 2023
Acute Myeloid Leukemia, MDS Trial in Omaha (ONC201)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Aug 4, 2022
Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Villejuif (Everolimus, ONC201, Radiotherapy)
Not yet recruiting
- Diffuse Intrinsic Pontine Glioma
- Diffuse Midline Glioma, H3 K27M-Mutant
- Everolimus
- +2 more
-
Villejuif, Val De Marne, FranceGustave Roussy
Jul 27, 2022
Diffuse Intrinsic Pontine Glioma, Glioma, Malignant Trial in United States (ONC201)
Recruiting
- Diffuse Intrinsic Pontine Glioma
- Glioma, Malignant
-
San Francisco, California
- +7 more
Mar 1, 2022
Metastatic Colorectal Cancer Trial in Providence (Dose level 1 ONC201 625mg, Dose level 2 ONC201 500mg, Dose level 3 ONC201
Terminated
- Metastatic Colorectal Cancer
- Dose level 1 ONC201 625mg
- +2 more
-
Providence, Rhode IslandLifespan Cancer Institute: The Miriam and Rhode Island Hospitals
May 25, 2022
Postoperative Pain Trial (Normal saline, Ropivacaine, Compound lidocaine)
Not yet recruiting
- Postoperative Pain
- Normal saline
- +3 more
- (no location specified)
Jul 20, 2023